651030-77-2

Basic information

• Product Name: 6-amino-5-nitro-4-(β-D-ribofuranosyl-5-t-butyldiphenylsilyloxy-1,2-dibenzoyl)pyrimidine
• Synonyms: 6-amino-5-nitro-4-(β-D-ribofuranosyl-5-t-butyldiphenylsilyloxy-1,2-dibenzoyl)pyrimidine
• CAS NO: 651030-77-2
• Molecular Weight: 733.853
• Mol File: 651030-77-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6-amino-5-nitro-4-(β-D-ribofuranosyl-5-t-butyldiphenylsilyloxy-1,2-dibenzoyl)pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-amino-5-nitro-4-(β-D-ribofuranosyl-5-t-butyldiphenylsilyloxy-1,2-dibenzoyl)pyrimidine(651030-77-2)
• EPA Substance Registry System: 6-amino-5-nitro-4-(β-D-ribofuranosyl-5-t-butyldiphenylsilyloxy-1,2-dibenzoyl)pyrimidine(651030-77-2)

Safety Data

• Hazardous Substances Data: 651030-77-2(Hazardous Substances Data)

Upstream product

• 651013-63-7 β-D-ribofuranose 5-t-butyldiphenylsilyloxy-2,3,5-tribenzoate 
• 2164-84-3 4,6-Diamino-5-nitropyrimidine 

Downstream Products

• 651013-64-8 6-amino-5-nitro-4-(β-D-ribofuranosylamino-2,3-dibenzoyl)pyrimidine 

Relevant articles and documents

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

The invention encompasses nucleoside compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.